Press Conference from Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer

Rosalyn A. Juergens,John Wrangle,Frank P. Vendetti,Sara C. Murphy,Ming Zhao,Barbara Coleman,Rosa Sebree,Kristen Rodgers,Craig M. Hooker, Noreli Franco,Beverly Lee, Salina Tsai, Igor Espinoza Delgado,Michelle A. Rudek,Steven A. Belinsky, James G. Herman, Stephen B. Baylin,Malcolm V. Brock,Charles M. Rudin

crossref（2023）

引用 0|浏览26

暂无评分

摘要

mp3 file (49.6MB). Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential for this population. Cancer Discovery Editors-in-Chief Jose Baselga, M.D., Ph.D. and Lewis C. Cantley, Ph.D. moderated a press conference about this research on Wednesday, Nov. 9, 2011.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要